BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21416664)

  • 1. Protein-protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome.
    Santucci L; Candiano G; Petretto A; Pavone B; Bruschi M; Gusmano R; Federici G; Urbani A; Ghiggeri GM
    Mol Biosyst; 2011 Mar; 7(3):659-66. PubMed ID: 21416664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
    Awadallah S; Madkour M; Hamidi RA; Alwafa EA; Hattab M; Zakkour B; Al-Matroushi A; Ahmed E; Al-Kitbi M
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S543-S546. PubMed ID: 28416369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
    Digre A; Nan J; Frank M; Li JP
    Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient purification of Apolipoprotein A1 (ApoA1) from plasma by HEA HyperCel™: An alternative approach.
    G AG; Kamalanathan AS; Vijayalakshmi MA; Venkataraman K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():104-109. PubMed ID: 29248767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly.
    Gulshan K; Brubaker G; Conger H; Wang S; Zhang R; Hazen SL; Smith JD
    Circ Res; 2016 Sep; 119(7):827-38. PubMed ID: 27514935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
    Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function.
    Filou S; Lhomme M; Karavia EA; Kalogeropoulou C; Theodoropoulos V; Zvintzou E; Sakellaropoulos GC; Petropoulou PI; Constantinou C; Kontush A; Kypreos KE
    Biochemistry; 2016 Jul; 55(27):3752-62. PubMed ID: 27332083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency.
    Nuño-Ayala M; Guillén N; Navarro MA; Lou-Bonafonte JM; Arnal C; Gascón S; Barranquero C; Godino J; Royo-Cañas M; Sarría AJ; Guzmán MA; Hernandez E; Bregante MA; García-Gimeno MA; Osada J
    Atherosclerosis; 2010 Sep; 212(1):268-73. PubMed ID: 20537649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Cholesterol Binding Drives Drastic Structural Alterations in Apolipoprotein A1.
    Ray A; Ghosh A; Chakraborty R; Upadhyay SK; Maiti S; Sengupta S; Thukral L
    J Phys Chem Lett; 2018 Oct; 9(20):6060-6065. PubMed ID: 30256643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins.
    Hajri T; Elliott-Bryant R; Sipe JD; Liang JS; Hayes KC; Cathcart ES
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):209-18. PubMed ID: 9795222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins.
    Pourmousa M; Song HD; He Y; Heinecke JW; Segrest JP; Pastor RW
    Proc Natl Acad Sci U S A; 2018 May; 115(20):5163-5168. PubMed ID: 29712830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
    Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
    Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
    Boisvert WA; Black AS; Curtiss LK
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.